{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:25:47Z","timestamp":1792790747822,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia, project number","id":[{"id":"https:\/\/ror.org\/00q919b81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2, continues to spread rapidly around the world, there is a need for well validated serological assays that allow the detection of viral specific antibody responses in COVID-19 patients or recovered individuals. In this study, we established and used multiple indirect Enzyme Linked Immunosorbent Assay (ELISA)-based serological assays to study the antibody response in COVID-19 patients. In order to validate the assays we determined the cut off values, sensitivity and specificity of the assays using sera collected from pre-pandemic healthy controls, COVID-19 patients at different time points after disease-onset, and seropositive sera to other human coronaviruses (CoVs). The developed SARS-CoV-2 S1 subunit of the spike glycoprotein and nucleocapsid (N)-based ELISAs not only showed high specificity and sensitivity but also did not show any cross-reactivity with other CoVs. We also show that all RT-PCR confirmed COVID-19 patients tested in our study developed both virus specific IgM and IgG antibodies as early as week one after disease onset. Our data also suggest that the inclusion of both S1 and N in serological testing would capture as many potential SARS-CoV-2 positive cases as possible than using any of them alone. This is specifically important for tracing contacts and cases and conducting large-scale epidemiological studies to understand the true extent of virus spread in populations.<\/jats:p>","DOI":"10.1038\/s41598-020-73491-5","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T06:04:06Z","timestamp":1601964246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Abdullah","family":"Algaissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Alfaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif","family":"Hala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki S.","family":"Abujamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan S.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Almahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alluhaybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya I.","family":"Hobani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem M.","family":"Alsulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf H.","family":"AlHarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-Z.aki","family":"ElAssouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowa Y.","family":"Alhabbab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahdab A.","family":"AlSaieedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam H.","family":"Abdulaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah A.","family":"Al-Somali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadwa S.","family":"Alofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim A.","family":"Khogeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almohanad A.","family":"Alkayyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Bakur","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif A. M.","family":"Almontashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-2819","authenticated-orcid":false,"given":"Arnab","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-7011","authenticated-orcid":false,"given":"Anwar M.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"73491_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 382, 727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017 (2020).","journal-title":"N. Engl. J. Med."},{"key":"73491_CR2","unstructured":"Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734). The U.S. Food and Drug Administration (FDA)https:\/\/www.fda.gov\/media\/137566\/download (2020)."},{"key":"73491_CR3","unstructured":"Russian Ministry of Health approves the first COVID-19 drug Avifavir produced by JV of RDIF and ChemRar. Russian Direct Investment Fundhttps:\/\/rdif.ru\/Eng_fullNews\/5220\/ (2020)."},{"key":"73491_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","volume":"66","author":"PS Masters","year":"2006","unstructured":"Masters, P. S. The molecular biology of coronaviruses. Adv. Virus Res. 66, 193\u2013292. https:\/\/doi.org\/10.1016\/S0065-3527(06)66005-3 (2006).","journal-title":"Adv. Virus Res."},{"key":"73491_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr, A. R. & Perlman, S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282, 1\u201323. https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_1 (2015).","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"73491_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2004.10.001","volume":"65","author":"YJ Tan","year":"2005","unstructured":"Tan, Y. J., Lim, S. G. & Hong, W. Characterization of viral proteins encoded by the SARS-coronavirus genome. Antivir. Res. 65(2), 69\u201378. https:\/\/doi.org\/10.1016\/j.antiviral.2004.10.001 (2005).","journal-title":"Antivir. Res."},{"key":"73491_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2019.01.005","volume":"466","author":"AM Hashem","year":"2019","unstructured":"Hashem, A. M. et al. Development and validation of different indirect ELISAs for MERS-CoV serological testing. J. Immunol. Methods 466, 41\u201346. https:\/\/doi.org\/10.1016\/j.jim.2019.01.005 (2019).","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"73491_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jiph.2020.01.001","volume":"13","author":"AA Degnah","year":"2020","unstructured":"Degnah, A. A. et al. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011\u20132016. J. Infect. Public Health 13(5), 697\u2013703. https:\/\/doi.org\/10.1016\/j.jiph.2020.01.001 (2020).","journal-title":"J. Infect. Public Health"},{"issue":"2","key":"73491_CR9","doi-asserted-by":"publisher","first-page":"2000763","DOI":"10.1183\/13993003.00763-2020","volume":"56","author":"B Lou","year":"2020","unstructured":"Lou, B. et al. Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset. Eur. Respir. J. 56(2), 2000763. https:\/\/doi.org\/10.1183\/13993003.00763-2020 (2020).","journal-title":"Eur. Respir. J."},{"issue":"6485","key":"73491_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485), 1444\u20131448. https:\/\/doi.org\/10.1126\/science.abb2762 (2020).","journal-title":"Science"},{"issue":"2","key":"73491_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jmv.24948","volume":"90","author":"S Trivedi","year":"2018","unstructured":"Trivedi, S. et al. Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection. J. Med. Virol. 90(2), 367\u2013371. https:\/\/doi.org\/10.1002\/jmv.24948 (2018).","journal-title":"J. Med. Virol."},{"key":"73491_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138759","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI138759 (2020).","journal-title":"J. Clin. Investig."},{"issue":"6","key":"73491_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26(6), 845\u2013848. https:\/\/doi.org\/10.1038\/s41591-020-0897-1 (2020).","journal-title":"Nat. Med."},{"issue":"1","key":"73491_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1080\/22221751.2020.1780951","volume":"9","author":"WN Chia","year":"2020","unstructured":"Chia, W. N. et al. Serological differentiation between COVID-19 and SARS infections. Emerg. Microbes Infect. 9(1), 1497\u20131505. https:\/\/doi.org\/10.1080\/22221751.2020.1780951 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"73491_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036. https:\/\/doi.org\/10.1038\/s41591-020-0913-5 (2020).","journal-title":"Nat. Med."},{"issue":"1","key":"73491_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/22221751.2020.1752610","volume":"9","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster. Emerg. Microbes Infect. 9(1), 924\u2013927. https:\/\/doi.org\/10.1080\/22221751.2020.1752610 (2020).","journal-title":"Emerg. Microbes Infect."},{"issue":"7","key":"73491_CR17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"NMA Okba","year":"2020","unstructured":"Okba, N. M. A. et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg. Infect. Dis. 26(7), 1478\u20131488. https:\/\/doi.org\/10.3201\/eid2607.200841 (2020).","journal-title":"Emerg. Infect. Dis."},{"issue":"15","key":"73491_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/ciaa310","volume":"71","author":"L Guo","year":"2020","unstructured":"Guo, L. et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin. Infect. Dis. 71(15), 778\u2013785. https:\/\/doi.org\/10.1093\/cid\/ciaa310 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"73491_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3201\/eid2206.160010","volume":"22","author":"AN Alshukairi","year":"2016","unstructured":"Alshukairi, A. N. et al. Antibody response and disease severity in healthcare worker MERS survivors. Emerg. Infect. Dis. 22(6), 1113\u20131115. https:\/\/doi.org\/10.3201\/eid2206.160010 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"73491_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virusres.2014.03.018","volume":"194","author":"B Meyer","year":"2014","unstructured":"Meyer, B., Drosten, C. & M\u00fcller, M. A. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 194, 175\u2013183. https:\/\/doi.org\/10.1016\/j.virusres.2014.03.018 (2014).","journal-title":"Virus Res."},{"issue":"6505","key":"73491_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abc5343","volume":"369","author":"W Deng","year":"2020","unstructured":"Deng, W. et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 369(6505), 818\u2013823. https:\/\/doi.org\/10.1126\/science.abc5343 (2020).","journal-title":"Science"},{"issue":"6505","key":"73491_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1126\/science.abc4776","volume":"369","author":"A Chandrashekar","year":"2020","unstructured":"Chandrashekar, A. et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 369(6505), 812\u2013817. https:\/\/doi.org\/10.1126\/science.abc4776 (2020).","journal-title":"Science"},{"issue":"16","key":"73491_CR23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","volume":"323","author":"C Shen","year":"2020","unstructured":"Shen, C. et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323(16), 1582\u20131589. https:\/\/doi.org\/10.1001\/jama.2020.4783 (2020).","journal-title":"JAMA"},{"key":"73491_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2598-9","author":"J Braun","year":"2020","unstructured":"Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature https:\/\/doi.org\/10.1038\/s41586-020-2598-9 (2020).","journal-title":"Nature"},{"issue":"7","key":"73491_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1473-3099(20)30273-5","volume":"20","author":"SEF Yong","year":"2020","unstructured":"Yong, S. E. F. et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect. Dis. 20(7), 809\u2013815. https:\/\/doi.org\/10.1016\/S1473-3099(20)30273-5 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"73491_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du, L. et al. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7(3), 226\u2013236. https:\/\/doi.org\/10.1038\/nrmicro2090 (2009).","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"73491_CR27","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1128\/JVI.02605-06","volume":"81","author":"D Vijaykrishna","year":"2007","unstructured":"Vijaykrishna, D. et al. Evolutionary insights into the ecology of coronaviruses. J. Virol. 81(8), 4012\u20134020. https:\/\/doi.org\/10.1128\/JVI.02605-06 (2007).","journal-title":"J. Virol."},{"issue":"7","key":"73491_CR28","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3201\/eid1107.041165","volume":"11","author":"A Wilder-Smith","year":"2005","unstructured":"Wilder-Smith, A. et al. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg. Infect. Dis. 11(7), 1142\u20131145. https:\/\/doi.org\/10.3201\/eid1107.041165 (2005).","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"73491_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S1473-3099(20)30114-6","volume":"20","author":"X Pan","year":"2020","unstructured":"Pan, X. et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect. Dis. 20(4), 410\u2013411. https:\/\/doi.org\/10.1016\/S1473-3099(20)30114-6 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"73491_CR30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/infdis\/jiaa119","volume":"221","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China. J. Infect. Dis. 221(11), 1770\u20131774. https:\/\/doi.org\/10.1093\/infdis\/jiaa119 (2020).","journal-title":"J. Infect. Dis."},{"issue":"7","key":"73491_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jmv.25786","volume":"92","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J. Med. Virol. 92(7), 903\u2013908. https:\/\/doi.org\/10.1002\/jmv.25786 (2020).","journal-title":"J. Med. Virol."},{"key":"73491_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.26.20044222","author":"J An","year":"2020","unstructured":"An, J. et al. Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test. medRxiv https:\/\/doi.org\/10.1101\/2020.03.26.20044222 (2020).","journal-title":"medRxiv"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73491-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73491-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73491-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:20:23Z","timestamp":1670340023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73491-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73491"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73491-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16561"}}